Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Alimentary Pharmacology & Therapeutics
|
November 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Antiviral Therapy
|
April 6, 2013
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results
Stefan Zeuzem, Tarik Asselah, Peter Angus, et al.
The Lancet. Gastroenterology & Hepatology
|
June 26, 2020
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, et al.
Clinical Transplantation
|
December 13, 2023
Impact of Share 35 liver transplantation allocation in Australia and New Zealand
Michael A Fink, Paul J Gow, Geoffrey W McCaughan, et al.
Journal of Hepatology
|
May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection
Gail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
The New England Journal of Medicine
|
September 26, 2025
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy
Julian D Gillmore, Ed Gane, Jörg Täubel, et al.
Journal of Hepatology
|
October 27, 2019
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial
Gregory J Dore, Jordan J Feld, Alex Thompson, et al.
Hepatology International
|
July 24, 2015
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Hepatology (Baltimore, Md.)
|
August 12, 2020
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Journal of Hepatology
|
December 13, 2022
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
Lung-Yi Mak, Ed Gane, Christian Schwabe, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Alimentary Pharmacology & Therapeutics
|
November 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Antiviral Therapy
|
April 6, 2013
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results
Stefan Zeuzem, Tarik Asselah, Peter Angus, et al.
The Lancet. Gastroenterology & Hepatology
|
June 26, 2020
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, et al.
Clinical Transplantation
|
December 13, 2023
Impact of Share 35 liver transplantation allocation in Australia and New Zealand
Michael A Fink, Paul J Gow, Geoffrey W McCaughan, et al.
Journal of Hepatology
|
May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection
Gail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
The New England Journal of Medicine
|
September 26, 2025
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy
Julian D Gillmore, Ed Gane, Jörg Täubel, et al.
Journal of Hepatology
|
October 27, 2019
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial
Gregory J Dore, Jordan J Feld, Alex Thompson, et al.
Hepatology International
|
July 24, 2015
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Hepatology (Baltimore, Md.)
|
August 12, 2020
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Journal of Hepatology
|
December 13, 2022
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
Lung-Yi Mak, Ed Gane, Christian Schwabe, et al.
Page
of 8